Edward D. Breen - 05 Nov 2026 Form 4 Insider Report for DuPont de Nemours, Inc. (DD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Nov 2026, 17:21:24 UTC
Prior SEC filing
02 Oct 2026
Next SEC filing
16 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Paige Fleming by Power of Attorney
Filing notes and source

Key filing fact

Edward D. Breen filed Form 4 for DuPont de Nemours, Inc. (DD) on 09 Nov 2026.

Key facts

  • This page summarizes Edward D. Breen's Form 4 filing for DuPont de Nemours, Inc. (DD).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 09 Nov 2026, 17:21.

Change

  • Previous filing in this sequence was filed on 02 Oct 2026.
  • Current net transaction value: -$13,154,206.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001223619 Primary reporting owner

BREEN EDWARD D

Relationship
Director
Address
CHESTNUT RUN PLAZA 730, 974 CENTRE ROAD, WILMINGTON
Signature
Paige Fleming by Power of Attorney
Signature date
09 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DD transaction

Common Stock

Gift

Transaction value
Shares
+35,551
Change %
+39%
Price
$0.000000*
Shares after
127,276
Date
28 Aug 2026
Ownership
Direct
Footnotes
F1, F2
DD transaction

Common Stock

Options Exercise

Transaction value
Shares
+89,845
Change %
+71%
Price
$108.84*
Shares after
217,121
Date
05 Nov 2026
Ownership
Direct
DD transaction

Common Stock

Sale

Transaction value
-$13,154,206
Shares
-89,845
Change %
-41%
Price
$146.41
Shares after
127,276
Date
05 Nov 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DD transaction Derivative

Stock Options (Right to Buy NQOs)

Options Exercise

Transaction value
Shares
+89,845
Change %
Price
$0.000000*
Shares after
0
Date
05 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
89,845
Exercise price
$108.84
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents annuity payment back to Mr. Breen from 2024 GRAT 9.

Footnote F2

Includes acquisition of shares pursuant to dividend reinvestment.

Footnote F3

Weighted average sales price of $146.4176. Trades ranged from $144.04 to $149.28. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.

Footnote F4

Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant, option shares may be used to satisfy withholding taxes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .